Top compounds associated with response to CLDN4


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.2 1e-05
mRNA lapatinib GDSC1000 pan-cancer AAC 0.31 1e-05
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.18 1e-05
mRNA Doxorubicin gCSI pan-cancer AAC -0.28 1e-05
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.18 1e-05
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.21 1e-05
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.2 2e-05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA CEP-701 GDSC1000 pan-cancer AAC -0.19 2e-05
Download CSV